Cambrex Acquires Q1 Scientific

Purchase adds world-class stability storage capabilities to Cambrex’s expanding portfolio of outsourced pharmaceutical services.

Author Image

By: Charlie Sternberg

Associate Editor

Cambrex, a global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, has acquired Q1 Scientific, a provider of environmentally-controlled cGMP stability storage services for the pharmaceutical, medical device and life science industries, strategically located in Waterford, Ireland.   “Stability storage and testing is a critical component of drug development and commercialization of n...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters